CXCL12/CXCR4 axis governs Treg spatial dominance over CD8+ T cells via IL-2 sequestration: a dual therapeutic target in prostate cancer
BackgroundProstate cancer (PCa) is characterized by high incidence and recurrence rates, presenting as an immune ‘cold’ tumor that exhibits a poor response to immunotherapy. The mechanisms underlying immune suppression and evasion within the tumor microenvironment (TME) of PCa remain inadequately un...
Saved in:
Main Authors: | Junyi Li, Long Zhang, Ruoyang Liu, Changwen Xu, HuiHui Tang, Yunfei Zou, Qingfei Cao, Weichao Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1626708/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01) -
Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01) -
Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01) -
CXCR1, TLR-4, AND CXCL8: KEY MEDIATORS OF PSEUDOMONAS AERUGINOSA VIRULENCE IN WOUND AND BURN INFECTIONS
by: Muslim Idan Mohsin, et al.
Published: (2019-08-01) -
CXCL16/CXCR6 axis arises as a potential peripheral biomarker of early COPD development – results from a pilot study
by: Patrice Marques, et al.
Published: (2025-07-01)